Drugs / Subcutaneous depot medroxyprogesterone acetate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02509767 | Aug 2015 → Apr 2017 | — | Planned Parenthood Federation of America | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Subcutaneous depot medroxyprogesterone acetate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02509767 ↗ |
| Route | Subcutaneous | “receive subcutaneous depot medroxyprogesterone acetate (DMPA sc) injection administered by a clinic nurse” NCT02509767 ↗ |